All Stories

  1. Molecular Typing Reveals Distinct Mycoplasma genitalium Transmission Networks among a Cohort of Men Who Have Sex with Men and a Cohort of Women in France
  2. Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Badalona, Spain
  3. Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials
  4. Ureaplasma parvum causes hyperammonemia presenting as refractory status epilepticus after kidney transplant
  5. Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium
  6. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
  7. High Prevalence of Integrative and Conjugative Elements Encoding Transcription Activator-Like Effector Repeats in Mycoplasma hominis
  8. Incidence of sexually transmitted infections during pre-exposure prophylaxis for HIV: a worrying outcome at 2 years!
  9. Random transposon insertion in the Mycoplasma hominis minimal genome
  10. An unexpected case of Bartonella alsatica prosthetic vascular graft infection
  11. High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program
  12. A case of Ureaplasma parvum meningitis in an adult after transphenoidal ablation of craniopharyngioma
  13. Retrospective Study Comparing WBC scan and 18F-FDG PET/CT in Patients with Suspected Prosthetic Vascular Graft Infection
  14. In vitro Evidence of Improved Antimicrobial Efficacy of Silver and Triclosan Containing Vascular Grafts Compared with Rifampicin Soaked Grafts
  15. Early prosthetic joint infection due to Ureaplasma urealyticum: Benefit of 16S rRNA gene sequence analysis for diagnosis
  16. Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France
  17. Comparison of Genus Specific PCR and Culture with or without Sonication for Microbiological Diagnosis of Vascular Graft Infection
  18. Generation of Mycoplasma hominis gene-targeted mutants by targeting-induced local lesions in genomes (TILLING)
  19. Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015
  20. Clinical and histologic features of Mycoplasma pneumoniae –related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causes
  21. French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays
  22. Multi-center evaluation of one commercial and 12 in-house real-time PCR assays for detection of Mycoplasma pneumoniae
  23. Interaction of Mycoplasma hominis PG21 with Human Dendritic Cells: Interleukin-23-Inducing Mycoplasmal Lipoproteins and Inflammasome Activation of the Cell
  24. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases
  25. Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens
  26. Fluoroquinolone-ResistantMycoplasma genitalium,Southwestern France
  27. Fatal nosocomial meningitis caused by Mycoplasma hominis in an adult patient: case report and review of the literature
  28. Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment
  29. Surface lipoproteome of Mycoplasma hominis PG21 and differential expression after contact with human dendritic cells
  30. Comparison of the Antimicrobial Properties of Silver Impregnated Vascular Grafts with and without Triclosan
  31. Mycoplasma pneumoniaeMonoclonal P1 Type 2c Outbreak, Russia, 2013
  32. Comparative “-omics” in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors
  33. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis
  34. Should White Blood Cell Scan be Replaced by 18F-FDG PET-CT in the Diagnosis of Prosthetic Vascular Graft Infection?
  35. Molecular Epidemiology of Mycoplasma pneumoniae: Genotyping Using Single Nucleotide Polymorphisms and SNaPshot Technology
  36. Prevalence and Macrolide Resistance of Mycoplasma genitalium in South African Women
  37. Gestion probabiliste des anti-infectieux dans les infections de prothèses vasculaires
  38. Diagnosis of Ureaplasma urealyticum Septic Polyarthritis by PCR Assay and Electrospray Ionization Mass Spectrometry in a Patient with Acute Lymphoblastic Leukemia: FIG 1
  39. COL02-05: Infections à Mycoplasma pneumoniae de l’adulte dans un CHU (2010 à 2012)
  40. Comparison of Mycoplasma pneumoniae Infections in Asthmatic Children Versus Asthmatic Adults
  41. Direct Detection of Macrolide Resistance in Mycoplasma genitalium Isolates from Clinical Specimens from France by Use of Real-Time PCR and Melting Curve Analysis
  42. Evaluation of Two Commercial Real-Time PCR Assays for Detection of Mycoplasma genitalium in Urogenital Specimens
  43. Prevalence of Mycoplasma genitalium Among HIV-Infected Women, Agence Nationale de Recherches sur le SIDA et les hépatites virales CO3 Aquitaine Cohort, France
  44. Identification and Subtyping of Clinically Relevant Human and Ruminant Mycoplasmas by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
  45. P2.048 Evaluation of Two Commercial Real-Time PCR Assays For Detection of Mycoplasma Genitalium in Urogenital Specimens
  46. O06.3 Macrolide Resistance of Mycoplasma Genitalium in France Directly Detected in Clinical Specimens by Real-Time PCR and Melting Curve Analysis
  47. Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection
  48. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.
  49. Infections à Mycoplasma hominis
  50. Multilocus Variable-Number Tandem-Repeat Analysis-Confirmed Emergence of a Macrolide Resistance-Associated Mutation in Mycoplasma pneumoniae during Macrolide Therapy for Interstitial Pneumonia in an Immunocompromised Child
  51. Detection of macrolide resistance in Mycoplasma genitalium in France
  52. The Spread of Mycoplasma pneumoniae Is Polyclonal in Both an Endemic Setting in France and in an Epidemic Setting in Israel
  53. Clonal Spread of Mycoplasma pneumoniae in Primary School, Bordeaux, France
  54. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity
  55. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics
  56. Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture
  57. Prevalence of Mycoplasma pneumoniae-associated respiratory tract infections in hospitalized children: results of a 4-year prospective study in Tunis
  58. Detection and susceptibility testing of Mycoplasma amphoriforme isolates from patients with respiratory tract infections
  59. First Report of Septic Arthritis Caused by Klebsiella oxytoca
  60. Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae
  61. Evaluation of the combination of the NucliSENS easyMAG® and the EasyQ® applications for the detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory tract specimens
  62. Life on Arginine for Mycoplasma hominis: Clues from Its Minimal Genome and Comparison with Other Human Urogenital Mycoplasmas
  63. Syphilis et VIH : à propos de 19 cas de découvertes concomitantes
  64. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis
  65. Evaluation of Five Commercial Real-Time PCR Assays for Detection of Mycoplasma pneumoniae in Respiratory Tract Specimens
  66. Mycoplasmes urogénitaux
  67. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis
  68. Healthcare workers' knowledge of the carriage of meticillin-resistant Staphylococcus aureus by patients: the first step in controlling spread
  69. Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae
  70. First Report of Macrolide-Resistant Strains and Description of a Novel Nucleotide Sequence Variation in the P1 Adhesin Gene in Mycoplasma pneumoniae Clinical Strains Isolated in France over 12 Years
  71. Mycoplasmes et chlamydiae: sensibilité et résistance aux antibiotiques
  72. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics
  73. Mycoplasma spp.
  74. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin
  75. Endocardites à Pasteurella sp. Deux cas
  76. Mechanisms of Drug Resistance in Mycoplasma pneumoniae
  77. In Vitro Development of Resistance to Six and Four Fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, Respectively
  78. Clarithromycin Resistance Associated Gene Mutations
  79. Résistance aux antibiotiques chez les mycoplasmes et les chlamydiae
  80. In Vitro Activities of the Newer Quinolones Garenoxacin, Gatifloxacin, and Gemifloxacin against Human Mycoplasmas
  81. In Vitro Selection and Characterization of Resistance to Macrolides and Related Antibiotics in Mycoplasma pneumoniae
  82. Infections à « Mycoplasma hominis »
  83. DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of Ureaplasma spp. and Mycoplasma hominis Resistant to Fluoroquinolones
  84. Strategy of antibiotic rotation: Long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia*
  85. Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis
  86. Culture-Negative Endocarditis Due to Chlamydia pneumoniae
  87. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae
  88. Les mycoplasmes en pathologie humaine
  89. Diagnostic biologique des infections à mycoplasmes